SMOC has developed a set of mouse models expressing humanized metabolic targets. These models are suitable to assess the efficacy of drugs targeting metabolic pathways proteins in fully immunocompetent mice.
|
Strain Name:C57BL/6Smoc-Gt(ROSA)26Sorem1(SA-FRT-2xpA-CAG-FRT-loxp-STOP-loxp-MLL-AF9-IRES-Luciferase-2A-tdTomato -WPRE-polyA)Smoc
Strain State:Embryo cryopreservation | Cat. NO.:NM-KI-190114
Research Application:Acute myelogenous leukemia model
|
|
|
Strain Name:C57BL/6Smoc-Gt(ROSA)26Sorem1(SA-Frt-2xpolyA-CAG-Frt-LSL-PNPLA3 I148M-IRES-GFP-wpre-polyA)Smoc
Strain State:Repository Live | Cat. NO.:NM-KI-200013
Research Application:rs738409:148 isoleucine to Methionine protein variant,I148M.Non-alcoholic fatty liver and hepatitis B cirrhosis research.
|
|
|
Strain Name:C57BL/6Smoc-Gt(ROSA)26Sorem1(CAG-FRT-LSL- SOD1(G94A)-IRES-EGFP-WPRE-pA)Smoc
Strain State:Sperm cryopreservation | Cat. NO.:NM-KI-200263
Disease Connection:amyotrophic lateral sclerosis type 1
|
|
|
Strain Name:C57BL/6Smoc-Gt(ROSA)26Sorem1(CAG-LSL-V5-TERT-IRES-Luciferase-2A-EGFP-WPRE-pA)Smoc
Strain State:Embryo cryopreservation | Cat. NO.:NM-KI-18035
Research Application:Telomerase
|
|
|
Strain Name:C57BL/6Smoc-Gt(ROSA)26Sorem1(SA-Frt-2xpolyA-CAG-Frt-LSL-TM6SF2-IRES-GFP-WPRE-PA)Smoc
Strain State:Embryo cryopreservation | Cat. NO.:NM-KI-200017
Research Application:Non-alcoholic fatty liver disease
|
|
|
Strain Name:FVB-Gt(ROSA)26Sorem1(pAPOE-CYP3A4)Smoc
Strain State:Embryo cryopreservation | Cat. NO.:NM-KI-18032
Research Application:metabolism
|
|
|
Strain Name:FVB-Gt(ROSA)26Sorem1(Gut-CYP3A4-IRES-tdTomato)Smoc
Strain State:Embryo cryopreservation | Cat. NO.:NM-KI-18033
Research Application:metabolism
|